Alberta Diabetes Institute to Study Use of Anti-Obesity Drug in Alström and Bardet-Biedl Patients
mcmurryjulie / Pixabay

Alberta Diabetes Institute to Study Use of Anti-Obesity Drug in Alström and Bardet-Biedl Patients

According to a publication from EurekAlert, a clinical trial of setmelanotide, an experimental anti-obesity drug, is set to begin soon at the Alberta Diabetes Institute (of the University of Alberta).…

Continue Reading Alberta Diabetes Institute to Study Use of Anti-Obesity Drug in Alström and Bardet-Biedl Patients
Trial Data Looks Promising for Experimental Alström Syndrome Treatment
TeroVesalainen / Pixabay

Trial Data Looks Promising for Experimental Alström Syndrome Treatment

According to a story from MarketWatch, the biopharmaceutical company Rhythm Pharmaceuticals, Inc., recently presented interim data from a Phase 2 trial of setmelanotide as a treatment for obesity associated with…

Continue Reading Trial Data Looks Promising for Experimental Alström Syndrome Treatment

Research Highlights Link Between Kidney Disease and Alstrom Syndrome

According to a story from uhb.nhs.uk, a recent study has drawn a link between chronic kidney disease and Alström syndrome. The research team is associated with the University Hospitals Birmingham…

Continue Reading Research Highlights Link Between Kidney Disease and Alstrom Syndrome
Close Menu